Tao Cheng

Tao Cheng

Auto-generated profile, based on publicly available information

Tao Cheng

Department of Rheumatology The First Affiliated Hospital of Soochow University Suzhou Jiangsu P. R. China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MWMingjun Wang
Mingjun Wang
JWJian Wu
Jian Wu
EZErye Zhou
Erye Zhou
XCXin Chang
Xin Chang
JGJianhe Gan
Jianhe Gan
TCTao Cheng
Tao Cheng

2 February 2017 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
MWMingjun Wang
Mingjun Wang
JWJian Hui Wu
Jian Hui Wu
YGYufan Guo
Yufan Guo
XCxin chang
xin chang
TCTao Cheng
Tao Cheng
Recent studies have revealed fibroblast-like synoviocytes (FLS) as a pivotal effector cell in the inflamed joint of rheumatoid arthritis (RA) patients. FLS exhibit high proliferation rates and constitutive expression of cytokines, contributing to the pathogenesis of RA. In this study, we found that the expression of tripartite motif-containing protein 3 (TRIM3), a candidate tumor suppressor gene, was lower in synovial tissue samples of RA patients than in that of healthy controls. We then investigated the role of TRIM3 on the proliferation and cytokine secretion of primary cultured FLS from RA patients. Enforced expression of TRIM3 in RA FLS led to significantly decreased cell proliferation as indicated by Cell Counting Kit-8 assay, reduced secretion of tumor necrosis factor-α (TNF)-α, interleukin (IL)-1β and IL-6 as indicated by enzyme-linked immunosorbent assays, and decreased p38 phosphorylation as assessed by western blot analysis. The proteins promoting cell cycles (cyclin D1 and PCNA) were downregulated and the protein negatively regulating cell cycle progression (p53 and p21) was upregulated after TRIM3 overexpression. Importantly, TRIM3 knockdown had reverse effects on cell proliferation, which was suppressed by the p38-specific inhibitor SB203580. In conclusion, the current results demonstrated the downregulation of TRIM3 expression in RA synovial tissues. Importantly, TRIM3 exerted an anti-proliferation role in RA FLS via p38 signaling pathway.